1. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324-330.

2. Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol 1999;10:221-226.

3. Sharma S, Brown GC, Brown MM, Shah GK, Snow K, Brown H, Hollands H. Converting visual acuity to utilities. Can J Ophthalmol 2000;35:267-272.

4. Brown GC. Vision and quality of life. Trans Am Ophthalmol Soc 1999;97:473-512.

5. Brown GC, Sharma S, Brown MM, Kistler J. Utility values associated with age-related macular degeneration. Arch Ophthalmol 2000;118:47-51.

6. Brown GC, Brown MM, Sharma S, Brown H. Patient perceptions of bilateral visual loss. A utility value analysis. International Ophthalmology 2000;22:307-312.

7. Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P. Quality-of-life associated with diabetes mellitus in an adult population. Journal of Diabetes and Its Complications 2000;14:18-24.

8. Brown GC, Brown MM, Sharma S. Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration. Can J Ophthalmol 2000;35:27-32.

9. Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol 2001;85:327-331.

10. Brown MM, Brown GC, Sharma S, Brown H, Busbee B. Quality-of-life associated with unilateral and bilateral good vision. Ophthalmology 2001;108:643-647.

11. Brown GC, Brown MM, Sharma S, Beauchamp G, Hollands H. The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc 2001;99:199-203.

12. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK, Sharma SM. Improvement in quality of life from photodynamic therapy: a Canadian perspective. Can J Ophthalmol 2001;36:332-338.

13. Hollands H, Lam M, Pater J, Albiani D, Brown GC, Brown MM, Cruess AF, Sharma S. Reliability of the time trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol 2001;36:202-209.

14. Brown MM, Brown GC, Sharma S, Smith AF, Landy J. A utility analysis correlation with visual acuity: Methodologies and vision in the better and poorer eyes. International Ophthalmology 2001;24:123-127.

15. Landy J, Stein JD, Brown GC, Brown MM, Sharma S. Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus. Medical Science Monitor 2002;8:543-548.

16. Brown MM, Brown GC, Sharma S, Hollands H. Quality-of-life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol 2002;86:8.

17. Sharma S, Brown GC, Brown MM, Hollands H, Robbins R, Shah G. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol 2002;86:493-496.

18. Stein J, Brown GC, Brown MM, Sharma S, Hollands, Stein HD. The quality of life of patients with hypertension. J Clin Hypertension 2002;4:181-188.

19. Brown MM, Brown GC, Sharma S, Landy J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 2002;120:481-484.

20. Stein JD, Brown MM, Brown GC, Sharma S, Hollands H. Quality of life with macular degeneration. Perceptions of patients, clinicians and community members. Brit J Ophthalmol 2003;87:8-12.

21. Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with visual loss. Time tradeoff utility analysis comparison with systemic health states Ophthalmology 2003;110:1076-1081.

22. Sharma S, Oliver A, Bakal J, Hollands H, Brown GC, Brown MM. Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol 2003;87:259-61.

23. Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with visual loss. Time tradeoff utility analysis comparison with systemic health states Ophthalmology 2003;110:1076-1081.

24. Brown MM, Brown GC. Utility assessment and dry eye disease. Ophthalmology 2004;111:852-3.

25. Brown MM, Brown GC, Sharma S. Value-Based Medicine Analysis. The quality of life associated with blindness. Evidence-Based Ophthalmology 2006;7:93-100.

26. Brown MM, Brown GC, Sharma S. Value-Based Medicine Analysis. The quality of life associated with blindness. Evidence-Based Ophthalmology 2006;7:93-100.

27. Brown MM, Brown GC. The high value of low vision. Evidence-Based Ophthalmology 2006;7:108-109.

28. Brown GC, Brown MM. Leaving on a good note. Evidence-Based Ophthalmology 2007;8:8-9.

29. Brown MM, Brown GC. First and second eye models revisited. Evidence-Based Ophthalmology 2007;8:249-253.

30. Luo BP, Brown GC, Luo SC, Brown MM. The quality-of-life associated with presbyopia. Am J Ophthalmol 2008 Feb 1; [Epub ahead of print].

31. Real FJ, Brown GC, Brown H, Brown MM. The effect of comorbidities upon patient health-related quality of life. Br J Ophthalmol 2008;92:770-4. Epub 2008 Apr 1.

32. Godshalk A, Brown GC, Brown H, Brown MM. The power of positive thinking: The mistake a doctor can make when relying solely on the power of medicine. Br J Ophthalmol 2008 Jun;92(6):783-7.

33. Brown GC, Brown MM, Brown HC, Peet J, Roth Z. Value-Based Medicine Analysis. Topical cyclosporine (Restasis) cost-utility analysis. Evidence-Based Ophthalmology 2009;10:166-71.

34. Brown MM, Brown GC. Cost-utility analysis. The pearl in the crown. Can J Ophthalmol 2010; 45:211-4.

35. Brown GC. Advances in quality-of-life and the financial independence of patients. Curr Opin Ophthalmol. 2012;23:161-2.

36. Chaudry I, Brown GC, Brown MM. Medical student perceptions of quality-of-life associated with vision loss. Can J Ophthalmol 2015; 50:217-24.

37. Brown GC, Yoo J, Brown MM, Turpcu A, Rajput Y. The burden of retinal venous occlusion: An assessment of fellow eyes in 1,000 cases. Ophthalmology Retina 2017;1: 404-414.

38. Brown GC, Brown MM, Stein JD, Smiddy WE, Ophthalmic Utility Research Study Group. Vision-related quality-of-life associated with unilateral and bilateral ocular conditions. Ophthalmology 2018; 125:965-971.

39. Brown MM, Brown GC. Quality of life and vitreoretinal interventions. Retina Specialist. 2018, June, pp 30-34.

40. Brown GC, Brown MM, Sharma S. The Five Senses: A Patient Preference-Based Comparative Analysis. Clin Res Ophthalmol 2018;1(1):1-8.

41. Brown GC, Brown MM. Healthcare stakeholder perceptions of vision loss. Surv Ophthalmol (in press).

42. DiScala G, Brown GC, Brown MM. Vision utilities in Italy and the United States. Are they similar? Eur J Ophthalmol (in press).